BioCatalystWatch
ARTLWorkspace / ARTL / OverviewCompany library
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC.

ARTELO BIOSCIENCES, INC. (ARTL)

Website

Price
Market cap
Next catalyst4Q 2026ART27.13 — DREAM · Phase 2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ART12.11

PreINDP1P2P3FilingApproved
ART26.12

Small molecule

FABP5

PreINDP2P3FilingApproved
Upcoming / outlook

ART27.13

Small molecule

CB1 × CB2

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ART26.12

Small molecule

FABP5

PreINDP2P3FilingApproved
Upcoming / outlook

ART27.13

Small molecule

CB1 × CB2

PreINDP1P2P3FilingApproved
Upcoming / outlook

ART12.11

PreINDP1P2P3FilingApproved

Other pipelines

ART27.13

Small molecule

CB1 × CB2

PreINDP1P2P3FilingApproved
ART27.13

Small molecule

CB1 × CB2

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ARTL PR & News

PR & News

ARTL SEC archive